Drug Patents owned by Noden Pharma
1. Drug name - TEKTURNA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8617595 | NODEN PHARMA | Galenic formulations of organic compounds |
Feb, 2026
(3 years from now) | |
|
US8617595
(Pediatric) | NODEN PHARMA | Galenic formulations of organic compounds |
Aug, 2026
(3 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 150MG BASE | TABLET;ORAL | Prescription |
| EQ 300MG BASE | TABLET;ORAL | Prescription |
2. Drug name - TEKTURNA HCT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8618172 | NODEN PHARMA | Galenical formulations of organic compounds |
Jul, 2028
(5 years from now) | |
Drugs and Companies using ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE ingredient
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 150MG BASE;12.5MG | TABLET;ORAL | Discontinued |
| EQ 150MG BASE;25MG | TABLET;ORAL | Discontinued |
| EQ 300MG BASE;12.5MG | TABLET;ORAL | Prescription |
| EQ 300MG BASE;25MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.